We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPHD.L Regulatory News (PHD)

  • There is currently no data for PHD

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Update on irrevocable undertakings

17 May 2021 16:58

RNS Number : 8997Y
Pollen Street Capital
17 May 2021
 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, IN OR INTO ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF SUCH JURISDICTION.

FOR IMMEDIATE RELEASE

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION.  

 

17 MAY 2021

RECOMMENDED Acquisitionofproactis holdings PLCbyCAFE BIDCO LIMITED

(a wholly-owned subsidiary of investment funds advised and managed byPOLLEN STREET CAPITAL LIMITED)

Update on irrevocable undertakings

On 30 April 2021, the boards of Cafe Bidco Limited ("Bidco") and Proactis Holdings plc ("Proactis") issued an announcement (the "Offer Announcement") that they had reached agreement on the terms and conditions of a recommended cash offer by Bidco for the entire issued and to be issued share capital of Proactis (the "Acquisition"). Unless otherwise defined, capitalised terms used in this announcement have the meaning given to them in the Offer Announcement.

 

In accordance with Rule 2.10 of the Takeover Code, Bidco stated in the Offer Announcement that it had received irrevocable undertakings to vote (or, where applicable, procure voting) in favour of the Scheme at the Court Meeting and the Special Resolutions to be proposed at the General Meeting (or in the event that the Acquisition is implemented by an Offer, to accept or procure acceptance of such Offer) in respect of, in aggregate, 44,995,141 Proactis Shares, representing approximately 47.10 per cent. of the existing issued ordinary share capital of Proactis as at 29 April 2021 (being the last Business Day prior to the date of the Offer Announcement).

Bidco is pleased to announce that it has now received additional irrevocable undertakings to vote (or, where applicable, procure voting) in favour of the Scheme at the Court Meeting and the Special Resolutions to be proposed at the General Meeting (or in the event that the Acquisition is implemented by an Offer, to accept or procure acceptance of such Offer) from T.A.P. Schaefers, G.J. Schaefers, R. Vermeulen, Sean McDonough, N. Tijssen, and Lombard Odier Asset Management (Europe) Limited in respect of, in aggregate, 2,880,375 Proactis Shares, representing approximately 3.02 per cent. of the existing issued ordinary share capital of Proactis as at 14 May 2021 (being the last Business Day prior to the date of this announcement) (the "Additional Irrevocable Undertakings"). Further details of the Additional Irrevocable Undertakings, including the circumstances in which they cease to be binding, are set out in the appendix to this announcement.

Together with the irrevocable undertakings included in the Offer Announcement, Bidco has therefore now received irrevocable undertakings to vote (or, where applicable, procure voting) in favour of the Scheme at the Court Meeting and the Special Resolutions to be proposed at the General Meeting (or in the event that the Acquisition is implemented by an Offer, to accept or procure acceptance of such Offer) in respect of, in aggregate, 47,875,516 Proactis Shares, representing approximately 50.11 per cent. of the existing issued ordinary share capital of Proactis as at 14 May 2021 (being the last Business Day prior to the date of this announcement).

Bidco and Proactis are continuing to work together to progress the Acquisition as expeditiously as possible and further information on the timetable for the Acquisition will be announced in due course.

 

Enquiries:

Houlihan Lokey +44 (0)20 7907 4200 (Financial Adviser to Bidco)Lawrence GuthrieMark FisherYashin Mody

Stand Agency (Communications adviser to Pollen Street Capital) Cait Dacey +44 (0) 7973 596 503

Further information

Houlihan Lokey, which is authorised and regulated by the FCA in the United Kingdom, is acting exclusively as financial adviser to Bidco and no one else in connection with the matters described in this announcement and will not be responsible to anyone other than Bidco for providing the protections afforded to clients of Houlihan Lokey or for providing advice in relation to the Acquisition or any other matters referred to in this announcement. Neither Houlihan Lokey nor any of its subsidiaries or affiliates owes or accepts any duty, liability or responsibility whatsoever (whether direct or indirect, whether in contract, in tort, under statute or otherwise) to any person who is not a client of Houlihan Lokey in connection with this announcement or any matter referred to in this announcement.

This announcement is for information purposes only and is not intended to, and does not, constitute or form part of any offer or inducement to sell or an invitation to purchase, otherwise acquire, subscribe for, sell or otherwise dispose of, any securities or the solicitation of an offer to buy any securities in any jurisdiction, pursuant to the Acquisition or otherwise.

Overseas Shareholders

This announcement has been prepared in accordance with and for the purpose of complying with the laws of England and Wales, the Takeover Code, the Market Abuse Regulation, the AIM Rules and the Disclosure Guidance and Transparency Rules and information disclosed may not be the same as that which would have been disclosed if this announcement had been prepared in accordance with the laws of jurisdictions outside England and Wales.

The release, publication or distribution of this announcement in or into certain jurisdictions other than the United Kingdom may be restricted by law and therefore any persons who are subject to the laws of any jurisdiction other than the United Kingdom should inform themselves of, and observe, any applicable requirements of their jurisdictions.

The availability of the Acquisition to Proactis Shareholders who are not resident in and citizens of the United Kingdom may be affected by the laws of the relevant jurisdictions in which they are located or of which they are citizens. Persons who are not resident in and citizens of the United Kingdom should inform themselves of, and observe, any applicable legal or regulatory requirements of their jurisdictions. In particular, the ability of persons who are not resident in and citizens of the United Kingdom to vote their Proactis Shares with respect to the Scheme at the Court Meeting, or to execute and deliver forms of proxy appointing another person to vote at the Court Meeting on their behalf, may be affected by the laws of the relevant jurisdictions in which they are located or of which they are a citizen. Any failure to comply with the applicable restrictions may constitute a violation of the securities laws of any such jurisdiction. To the fullest extent permitted by applicable law, the companies and persons involved in the Acquisition disclaim any responsibility or liability for the violation of such restrictions by any person.

Unless otherwise determined by Bidco or required by the Takeover Code, and permitted by applicable law and regulation, participation in the Acquisition will not be made available, directly or indirectly, in, into or from a Restricted Jurisdiction where to do so would violate the laws in that jurisdiction and no person may vote in favour of the Acquisition by any such use, means, instrumentality or from within a Restricted Jurisdiction or any other jurisdiction if to do so would constitute a violation of the laws of that jurisdiction. Accordingly, copies of this announcement and any formal documentation relating to the Acquisition are not being, and must not be, directly or indirectly, mailed or otherwise forwarded, distributed or sent in, into or from any Restricted Jurisdiction and persons receiving this announcement and all such documents relating to the Acquisition (including custodians, nominees and trustees) must not mail or otherwise forward, distribute or send them in, into or from any Restricted Jurisdiction. Doing so may render invalid any related purported vote in respect of the Acquisition. If the Acquisition is implemented by way of an Offer (unless otherwise permitted by applicable law and regulation), the Offer may not be made directly or indirectly, in or into, or by the use of mails or any means or instrumentality (including, but not limited to, facsimile, e-mail or other electronic transmission, telex or telephone) of interstate or foreign commerce of, or of any facility of a national, state or other securities exchange of, any Restricted Jurisdiction and the Offer may not be capable of acceptance by any such use, means, instrumentality or facilities.

Further details in relation to Overseas Shareholders will be contained in the Scheme Document.

Notice to US investors in Proactis 

Proactis Shareholders in the United States should note that the Acquisition relates to the shares of an English company and is proposed to be made by means of a scheme of arrangement provided for under, and governed by, the laws of England and Wales. If the Acquisition is carried out under such Scheme, it is expected that any Alternative Offer Securities issued pursuant to the Acquisition would be issued in reliance upon the exemption from the registration requirements under the US Securities Act provided by Section 3(a)(10) thereof and would not be registered under the US Securities Act. Securities issued pursuant to the Scheme will not be registered under any laws of any state, district or other jurisdiction of the United States, and may only be issued to persons resident in such state, district or other jurisdiction pursuant to an exemption from the registration requirements of such laws.

Neither the proxy solicitation nor the tender offer rules under the US Exchange Act will apply to the Scheme. Moreover, the Scheme will be subject to the disclosure and procedural requirements and practices applicable in the United Kingdom to schemes of arrangement, which differ from the disclosure requirements of US tender offer and proxy solicitation rules. If, in the future, Bidco exercises the right to implement the Acquisition by way of an Offer and determines to extend the offer into the United States, the Acquisition will be made in compliance with applicable United States laws and regulations, including any applicable exemptions under the US Exchange Act. Such an Offer would be made in the United States by Bidco and no one else. In accordance with normal United Kingdom practice and consistent with Rule 14e-5 under the US Exchange Act, Bidco, certain affiliated companies and the nominees or brokers (acting as agents) may make certain purchases of, or arrangements to purchase, shares in Proactis outside such Offer during the period in which such Offer would remain open for acceptance. If such purchases or arrangements to purchase were to be made they would be made outside the United States either in the open market at prevailing prices or in private transactions at negotiated prices and would comply with applicable law, including, to the extent applicable, the US Exchange Act. Any information about such purchases will be disclosed as required in the United Kingdom, will be reported to a Regulatory Information Service and will be available on the London Stock Exchange website at www.londonstockexchange.com.

The financial information included in this announcement and the Scheme Document (or, if the Acquisition is implemented by way of an Offer, the Offer Document) has been or will have been prepared in accordance with generally accepted accounting principles of the United Kingdom and thus may not be comparable to the financial information of US companies or companies whose financial statements are prepared in accordance with generally accepted accounting principles in the United States.

The receipt of consideration by a US holder for the transfer of its Proactis Shares pursuant to the Acquisition may be a taxable transaction for US federal income tax purposes and under applicable US state and local, as well as non-US and other, tax laws. Each Proactis Shareholder is urged to consult their independent professional adviser immediately regarding the tax consequences of the Acquisition applicable to them, including under applicable US federal, state and local, as well as non-US and other, tax laws.

It may be difficult for US holders of Proactis Shares to enforce their rights and any claim arising out of the US federal laws or to enforce against them a judgment of a US court predicated upon the securities laws of the United Kingdom, since Bidco and Proactis are incorporated in a non-US jurisdiction, and some or all of their officers and directors may be residents of countries other than the United States. US holders of Proactis Shares may not be able to sue a non-US company or its officers or directors in a non-US court for violations of the US securities laws. Further, it may be difficult to compel a non-US company and its affiliates to subject themselves to a US court's judgement.

Dealing and opening position disclosure requirements

Under Rule 8.3(a) of the Takeover Code, any person who is interested in one per cent. or more of any class of relevant securities of an offeree company or of any securities exchange offeror (being any offeror other than an offeror in respect of which it has been announced that its offer is, or is likely to be, solely in cash) must make an Opening Position Disclosure following the commencement of the offer period and, if later, following the announcement in which any securities exchange offeror is first identified.

An Opening Position Disclosure must contain details of the person's interests and short positions in, and rights to subscribe for, any relevant securities of each of (i) the offeree company and (ii) any securities exchange offeror(s). An Opening Position Disclosure by a person to whom Rule 8.3(a) applies must be made by no later than 3.30 p.m. (London time) on the 10th business day following the commencement of the offer period and, if appropriate, by no later than 3.30 p.m. (London time) on the 10th business day following the announcement in which any securities exchange offeror is first identified. Relevant persons who deal in the relevant securities of the offeree company or of a securities exchange offeror prior to the deadline for making an Opening Position Disclosure must instead make a Dealing Disclosure.

Under Rule 8.3(b) of the Takeover Code, any person who is, or becomes, interested in one per cent. or more of any class of relevant securities of the offeree company or of any securities exchange offeror must make a Dealing Disclosure if the person deals in any relevant securities of the offeree company or of any securities exchange offeror. A Dealing Disclosure must contain details of the dealing concerned and of the person's interests and short positions in, and rights to subscribe for, any relevant securities of each of (i) the offeree company and (ii) any securities exchange offeror, save to the extent that these details have previously been disclosed under Rule 8. A Dealing Disclosure by a person to whom Rule 8.3(b) applies must be made by no later than 3.30 p.m. (London time) on the business day following the date of the relevant dealing. If two or more persons act together pursuant to an agreement or understanding, whether formal or informal, to acquire or control an interest in relevant securities of an offeree company or a securities exchange offeror, they will be deemed to be a single person for the purpose of Rule 8.3.

Opening Position Disclosures must also be made by the offeree company and by any offeror and Dealing Disclosures must also be made by the offeree company, by any offeror and by any persons acting in concert with any of them (see Rules 8.1, 8.2 and 8.4). Details of the offeree and offeror companies in respect of whose relevant securities Opening Position Disclosures and Dealing Disclosures must be made can be found in the Disclosure Table on the Takeover Panel's website at www.thetakeoverpanel.org.uk, including details of the number of relevant securities in issue, when the offer period commenced and when any offeror was first identified. You should contact the Panel's Market Surveillance Unit on +44 (0)20 7638 0129 if you are in any doubt as to whether you are required to make an Opening Position Disclosure or a Dealing Disclosure.

Publication on a website

In accordance with Rule 26.1 of the Takeover Code, copies of this announcement and the Additional Irrevocable Undertakings will be made available, subject to certain restrictions relating to persons resident in Restricted Jurisdictions, on Proactis' website at https://www.proactis.com/uk/investors/ and Bidco's website at https://cafe.pollencap.com by no later than 12 noon (London time) on the first Business Day following the date of this announcement. For the avoidance of doubt, neither the contents of these websites nor any website accessible from hyperlinks is incorporated into or forms part of this announcement.

 

APPENDIXDETAILS OF ADDITIONAL IRREVOCABLE UNDERTAKINGS

1. T.A.P. Schaefers, G.J. Schaefers, R. Vermeulen,

Registered holder

Beneficial owner(s)

Total Number ofProactis Shares

Percentage of existing issued share capital

T.A.P Schaefers

T.A.P. Schaefers

228,500

0.24

FTB2 BV

T.A.P. Schaefers, G.J. Schaefers, R. Vermeulen (each as to 1/3 of the joint holding of 1,292,491)

1,292,491

1.35

G.J. Schaefers

G.J. Schaefers

99,200

0.10

 

 

 

 

T.A.P Schaefers, G.J. Schaefers and R. Vermeulen have each given irrevocable undertakings to vote (or, where applicable, procure voting) in favour of the Scheme at the Court Meeting and the Special Resolutions to be proposed at the General Meeting (or in the event that the Acquisition is implemented by an Offer, to accept or procure acceptance of such Offer) in respect of their own beneficial holdings of Proactis Shares:

The obligations contained in the irrevocable undertakings referred to in paragraph 1 above lapse and cease to have effect: (i) if Bidco announces that it does not intend to proceed with the Acquisition and no new, revised or replacement Scheme or Offer is announced by Bidco in accordance with Rule 2.7 of the Takeover Code at the same time; (ii) on the earlier of (A) the Long Stop Date; and (B) the date on which the Acquisition (whether implemented by way of a Scheme or an Offer) is withdrawn or lapses in accordance with its terms, save where such lapse or withdrawal is as a result of Bidco exercising its right to implement the Acquisition by way of an Offer rather than by way of a Scheme or vice versa in accordance with the Takeover Code; or (iii) if any third party announces a firm intention offer in accordance with Rule 2.7 of the Takeover Code for all of the issued and to be issued ordinary share capital of Proactis and the consideration payable for each Proactis Share under such proposal represents in the reasonable opinion of Bidco a premium of 20 per cent. or greater to the value of the consideration offered by Bidco on the last dealing day prior to such third party announcement and Bidco does not, within ten days of such third party announcement, announce an increase to the consideration to be paid for the Proactis Shares to at least an equivalent amount per Proactis Share as being offered under the competing proposal.

2. Sean McDonough

Sean McDonough has given an irrevocable undertaking to vote (or, where applicable, procure voting) in favour of the Scheme at the Court Meeting and the Special Resolutions to be proposed at the General Meeting (or in the event that the Acquisition is implemented by an Offer, to accept or procure acceptance of such Offer) in respect of his own beneficial holdings of Proactis Shares:

Registered holder

Beneficial owner(s)

Total Number ofProactis Shares

Percentage of existing issued share capital

Sean McDonough

Sean McDonough

621,666

0.65

Dowgate Capital

Sean McDonough

15,000

0.02

 

 

 

 

The obligations contained in the irrevocable undertaking referred to in paragraph 2 above lapse and cease to have effect: (i) if Bidco announces that it does not intend to proceed with the Acquisition and no new, revised or replacement Scheme or Offer is announced by Bidco in accordance with Rule 2.7 of the Takeover Code at the same time; (ii) on the earlier of (A) the Long Stop Date; and (B) the date on which the Acquisition (whether implemented by way of a Scheme or an Offer) is withdrawn or lapses in accordance with its terms, save where such lapse or withdrawal is as a result of Bidco exercising its right to implement the Acquisition by way of an Offer rather than by way of a Scheme or vice versa in accordance with the Takeover Code; or (iii) if any third party announces a firm intention offer in accordance with Rule 2.7 of the Takeover Code for all of the issued and to be issued ordinary share capital of Proactis and the consideration payable for each Proactis Share under such proposal represents in the reasonable opinion of Bidco a premium of 10 per cent. or greater to the value of the consideration offered by Bidco on the last dealing day prior to such third party announcement and Bidco does not, within ten days of such third party announcement, announce an increase to the consideration to be paid for the Proactis Shares to at least an equivalent amount per Proactis Share as being offered under the competing proposal.

3. N. Tijssen

N. Tijssen has given an irrevocable undertaking to vote (or, where applicable, procure voting) in favour of the Scheme at the Court Meeting and the Special Resolutions to be proposed at the General Meeting (or in the event that the Acquisition is implemented by an Offer, to accept or procure acceptance of such Offer) in respect of their own beneficial holdings of Proactis Shares:

Registered holder

Beneficial owner(s)

Total Number ofProactis Shares

Percentage of existing issued share capital

N. Tijssen

N. Tijssen

143,338

0.15

 

 

 

 

The obligations contained in the irrevocable undertaking referred to in paragraph 3 above lapse and cease to have effect: (i) if Bidco announces that it does not intend to proceed with the Acquisition and no new, revised or replacement Scheme or Offer is announced by Bidco in accordance with Rule 2.7 of the Takeover Code at the same time; (ii) on the earlier of (A) the Long Stop Date; and (B) the date on which the Acquisition (whether implemented by way of a Scheme or an Offer) is withdrawn or lapses in accordance with its terms, save where such lapse or withdrawal is as a result of Bidco exercising its right to implement the Acquisition by way of an Offer rather than by way of a Scheme or vice versa in accordance with the Takeover Code; or (iii) if any third party announces a firm intention offer in accordance with Rule 2.7 of the Takeover Code for all of the issued and to be issued ordinary share capital of Proactis and the consideration payable for each Proactis Share under such proposal represents in the reasonable opinion of Bidco a premium of 20 per cent. or greater to the value of the consideration offered by Bidco on the last dealing day prior to such third party announcement and Bidco does not, within ten days of such third party announcement, announce an increase to the consideration to be paid for the Proactis Shares to at least an equivalent amount per Proactis Share as being offered under the competing proposal.

4. Lombard Odier Asset Management (Europe) Limited

Lombard Odier Asset Management (Europe) Limited, acting in its capacity as discretionary investment manager or sub-adviser for and on behalf of certain funds and accounts managed by it and/or agent of Lombard Odier Asset Management (USA) Corp acting in its capacity as discretionary investment manager for and on behalf of certain funds and accounts managed by it has given irrevocable undertakings to vote (or, where applicable, procure voting) in favour of the Scheme at the Court Meeting and the Special Resolutions to be proposed at the General Meeting (or in the event that the Acquisition is implemented by an Offer, to accept or procure acceptance of such Offer) in respect of Proactis Shares held by funds and accounted managed by it:

Name

Total Number ofProactis Shares

Percentage of existing issued share capital

Lombard Odier Asset Management (Europe) Limited

28,546,863

29.88

 

 

 

The irrevocable undertakings referred to in paragraph 4 above replace the irrevocable undertakings provided by Lombard Odier Asset Management (Europe) Limited to Bidco dated 30 April 2021 in respect of 28,066,683 Proactis Shares and are in respect of an additional 480,180 Proactis Shares.

The obligations contained in the irrevocable undertaking referred to in paragraph 4 above lapse and cease to have effect if: (i) the Acquisition has not completed by 5.00 p.m. on the Long Stop Date; (ii) the Acquisition (whether implemented by way of a Scheme or an Offer) lapses or is withdrawn in a manner which is permitted by the Panel, save where such lapse or withdrawal is as a result of Bidco exercising its right to implement the Acquisition by way of an Offer rather than by way of a Scheme or vice versa in accordance with the Takeover Code; or (iii) any third party announces a firm intention offer in accordance with Rule 2.7 of the Takeover Code for all of the issued and to be issued ordinary share capital of Proactis and the consideration payable for each Proactis Share under such proposal represents a premium of 10 per cent. or greater to the value of the consideration offered by Bidco.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
OUPDKOBPPBKDPPD
Date   Source Headline
28th Jul 20217:00 amRNSCancellation - Proactis Holdings plc
27th Jul 20213:05 pmRNSScheme Effective
27th Jul 20217:30 amRNSSuspension - Proactis Holdings plc
26th Jul 20218:06 amRNSExercise of Options, PDMR Shareholding & TVR
23rd Jul 20212:25 pmRNSExercise of Options, PDMR Shareholding & TVR
23rd Jul 20212:00 pmRNSCourt Sanction of Scheme & Suspension
21st Jul 20215:30 pmRNSProactis Holdings
20th Jul 20214:25 pmRNSResults of Court Meeting and General Meeting
15th Jul 20213:13 pmRNSHolding(s) in Company
15th Jul 20219:18 amRNSForm 8.3 - [PROACTIS HOLDINGS PLC]
12th Jul 20211:37 pmRNSForm 8.3 - [PROACTIS HOLDING PLC]
9th Jul 20219:22 amRNSForm 8.3 - [PROACTIS HOLDINGS PLC]
8th Jul 20219:47 amRNSForm 8.3 - [PROACTIS HOLDINGS PLC]
1st Jul 20218:28 amRNSForm 8.3 - PROACTIS HOLDINGS PLC
29th Jun 20217:00 amRNSConclusion of cyber security incident
28th Jun 20215:55 pmRNSPosting of Scheme Document
21st Jun 20215:36 pmRNSForm 8 (OPD) Proactis Holdings plc
21st Jun 20217:00 amRNSbePayd Strategic Contract Win
18th Jun 20217:00 amRNSForm 8 (OPD) - Proactis Holdings Plc
11th Jun 20217:11 amRNSUpdate re. Recommended Acquisition of Proactis
11th Jun 20217:00 amRNSRecommended acquisition of Proactis Holdings
28th May 20219:12 amRNSTimetable for publication of the Scheme Document
21st May 20213:37 pmRNSNotice of cyber security incident
18th May 20217:00 amRNSStrategic Contract Win
17th May 20214:58 pmRNSUpdate on irrevocable undertakings
17th May 202111:10 amRNSForm 8.3 - Proactis Holdings plc
17th May 20219:13 amRNSFORM 8 (OPD) - Proactis Holdings Plc
13th May 202110:18 amBUSForm 8.3 - Proactis Holdings Plc
11th May 20215:22 pmRNSHolding(s) in Company
10th May 20213:03 pmRNSForm 8.3 - Proactis Holdings Plc
10th May 20217:00 amRNSForm 8.3 - Proactis Holdings PLC
7th May 202111:57 amRNSForm 8.3 - Proactis Holdings plc
6th May 20215:01 pmRNSForm 8.3 - Proactis Holdings PLC
6th May 202110:54 amRNSForm 8 (OPD) Proactis Holdings plc
5th May 20215:27 pmRNSHolding(s) in Company
5th May 20213:29 pmRNSForm 8.3 - Proactis Holdings Plc
5th May 20212:20 pmRNSForm 8.3 - Proactis Holdings PLC
5th May 202111:47 amRNSForm 8.3 - Proactis plc / Cafe Bidco Limited
4th May 20215:03 pmRNSForm 8.3 - Proactis Holdings Plc
4th May 20214:55 pmRNSHolding(s) in Company
4th May 20212:51 pmRNSForm 8 (DD) - Proactis Holdings Plc
4th May 20211:38 pmRNSForm 8.3 - Proactis / Cafe Bidco Limited
4th May 20211:32 pmRNSForm 8.3 - Proactis / Cafe Bidco Limited
4th May 20219:55 amRNSForm 8.3 - Proactis Holdings Plc
4th May 20217:00 amRNSInvestment in Vertu Motors plc & Notice of Results
30th Apr 20214:40 pmRNSSecond Price Monitoring Extn
30th Apr 20214:35 pmRNSPrice Monitoring Extension
30th Apr 20214:24 pmRNSNew LTIP, Grant of Options & PDMR Shareholdings
30th Apr 20214:06 pmRNSRecommended Acquisition of Proactis
30th Apr 20214:00 pmRNSRecommended acquisition of Proactis Holdings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.